Brief: Bellerophon Therapeutics Q3 Loss Per Share $0.84
05/11/2020 13:54
Nov 5 (Reuters) - Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON PROVIDES CLINICAL PROGRAM UPDATE AND REPORTS
THIRD
QUARTER 2020 FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.84
* Q3 EARNINGS PER SHARE ESTIMATE $-0.83 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX9BGJWq
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen